Ad is loading...

CRVS Corvus Pharmaceuticals Forecast, Technical & Fundamental Analysis

a provider of anticancer immuno-oncology drugs

Industry Biotechnology

Get AI intraday signals

CRVS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For CRVS
(Try 14 days for Free)

View a ticker or compare two or three

Compare

CRVS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For CRVS
(Try 14 days for Free)

Ad is loading...

A.I. Advisor

published Earnings

CRVS is expected to report earnings to fall 80.42% to -11 cents per share on March 06

Corvus Pharmaceuticals CRVS Stock Earnings Reports

Q4'24

Est.

$-0.12

Q3'24

Missed

by $0.49

Q2'24

Beat

by $0.05

Q1'24

Est.

$-0.12

Q4'23

Missed

by $0.02

The last earnings report on November 12 showed earnings per share of -60 cents, missing the estimate of -10 cents. With 2.35M shares outstanding, the current market capitalization sits at 526.27M.

A.I. Advisor

published General Information

General Information

a provider of anticancer immuno-oncology drugs

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

863 Mitten Road

Phone

+1 650 900-4520

Employees

Web

https://www.corvuspharma.com

Interesting Tickers

MFs / NAME	Price $	Chg $	Chg %
		1 Day
DRDIX	26.95	-0.20	-0.74%
Dearborn Partners Rising Dividend I
WASAX	22.61	-0.25	-1.09%
Delaware Ivy Asset Strategy Fund Cl A
FMSGX	15.24	-0.20	-1.30%
Frontier MFG Global Sustainable Instl
PIGFX	36.92	-0.65	-1.73%
Pioneer Fundamental Growth A
GGRUX	13.72	-0.31	-2.21%
Goldman Sachs Strategic Growth R6

CRVS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CRVS has been loosely correlated with VRDN. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if CRVS jumps, then VRDN could also see price increases.

Ticker / NAME	Correlation To CRVS	1D Price Change %
CRVS	100%	-3.87%
VRDN - CRVS	40% Loosely correlated	-6.93%
PLRX - CRVS	34% Loosely correlated	-3.27%
PRME - CRVS	34% Loosely correlated	-6.95%
FULC - CRVS	34% Loosely correlated	-9.49%
VCYT - CRVS	33% Poorly correlated	-2.97%
More